Veeva Systems (VEEV)
(Delayed Data from NYSE)
$214.88 USD
+0.49 (0.23%)
Updated Sep 20, 2024 03:57 PM ET
After-Market: $212.21 -2.67 (-1.24%) 5:00 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Price, Consensus and EPS Surprise
VEEV 214.88 +0.49(0.23%)
Will VEEV be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for VEEV based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for VEEV
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
VEEV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on It
Factors Driving Veeva Stock More Than 20% in Three Months
VEEV Stock Up Following the Release of New Features of Veeva Site Connect
Other News for VEEV
Veeva Systems Welcomes Brian Van Wagener as New CFO
Analyst Issues Sell Rating for Veeva Systems Ahead of Dreamforce Conference Amid Market Volatility Concerns
IHF: Healthcare Dashboard For September
Cloud Stocks: Salesforce Preps To Enter Veeva’s Territory
Fidelity Select Health Care Portfolio Q2 2024 Review